Prof. Dr. Xiubao Ren is the Director of Tianjin Key Laboratory of Cancer Immunology and Biotherapy. He is the current Director of the Department of Biotherapy and the Director of the Department of Immunology at TMUCIH. He is also the Deputy Director of the Professional Committee of Medical Biotechnology Clinical Application of CMBA and the Chairman of the Cancer Professional Committee of the Tianjin Branch of the Chinese Medical Association. His research areas include molecular mechanisms of tumor immunity and the development of innovative technologies for tumor biotherapy. In recent years, he has published more than one hundred and thirty papers, including more than eighty papers in SCI, and received three provincial and ministerial research awards. He was elected as the National Personnel Ministry's “Millions of Talents” award in 2012. He has undertaken several national scientific research projects, including the National Key R&D Program, National 863 Program, National 973 Program, and the National Natural Science Foundation of China.
Prof. Dr. Xiubao Ren is the Director of Tianjin Key Laboratory of Cancer Immunology and Biotherapy. He is the current Director of the Department of Biotherapy and the Director of the Department of Immunology at TMUCIH. He is also the Deputy Director of the Professional Committee of Medical Biotechnology Clinical Application of CMBA and the Chairman of the Cancer Professional Committee of the Tianjin Branch of the Chinese Medical Association. His research areas include molecular mechanisms of tumor immunity and the development of innovative technologies for tumor biotherapy. In recent years, he has published more than one hundred and thirty papers, including more than eighty papers in SCI, and received three provincial and ministerial research awards. He was elected as the National Personnel Ministry's “Millions of Talents” award in 2012. He has undertaken several national scientific research projects, including the National Key R&D Program, National 863 Program, National 973 Program, and the National Natural Science Foundation of China.